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Abstract
Progressive retinal degenerations are among the most common causes of
blindness both in human and in dogs. Canine progressive retinal atrophy (PRA)
resembles human retinitis pigmentosa (RP) and is typically characterized by a
progressive loss of rod photoreceptors followed by a loss of cone function. The
disease gradually progress from the loss of night and day vision to a complete
blindness. We have recently described a unique form of retinopathy characterized
by the multifocal gray/brown discoloration and thinning of the retina in the Swedish
Vallhund (SV) breed. We aimed to identify the genetic cause by performing a
genome wide association analysis in a cohort of 18 affected and 10 healthy control
dogs using Illumina’s canine 22k SNP array. We mapped the disease to canine
chromosome 17 (p57.761025) and found a 6.1 Mb shared homozygous region in
the affected dogs. A combined analysis of the GWAS and replication data with
additional 60 dogs confirmed the association (p54.361028, OR511.2 for
homozygosity). A targeted resequencing of the entire associated region in four
cases and four controls with opposite risk haplotypes identified several variants in
the coding region of functional candidate genes, such as a known retinopathy gene,
MERTK. However, none of the identified coding variants followed a compelling
case- or breed-specific segregation pattern. The expression analyses of four
candidate genes in the region, MERTK, NPHP1, ANAPC1 and KRCC1, revealed
specific upregulation of MERTK in the retina of the affected dogs. Collectively,
these results indicate that the retinopathy is associated with overexpression of
MERTK, however further investigation is needed to discover the regulatory
mutation for the better understanding of the disease pathogenesis. Our study
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establishes a novel gain-of-function model for the MERTK biology and provides a
therapy model for retinopathy MERTK inhibitors. Meanwhile, a marker-based
genetic counseling can be developed to revise breeding programs.
Introduction
Dogs suffer from hundreds of hereditary disorders according to the Online
Mendelian Inheritance in Animal database (OMIA, http://omia.angis.org.au/
home/) and many of them represent clinically and physiologically relevant models
for human conditions. Examples include several retinal conditions, such as canine
multifocal retinopathies (cmr) [1–2] and Leber congenital amaurosis (canine
LCA) [3]. Progressive retinal degenerations form a heterogeneous group of
disorders that affect different retinal cells such as photoreceptors or retinal
pigment epithelium (RPE), resulting in the impairment or complete loss of vision
(RetNet; http://www.sph.uth.tmc.edu/Retnet/). Retinitis pigmentosa (RP) is one
of the most common incurable blindness worldwide [4]. In RP, the degenerative
process typically starts from rod photoreceptors and expands to cone cells leading
to a progressive loss of both night- and day light vision before complete blindness
[5].
Canine progressive retinal degenerations resemble human RP and are
commonly referred as progressive retinal atrophies (PRA). PRA affects many
breeds with remarkable variation in the etiology, progression and onset. Careful
characterization of these conditions across breeds is not only important for the
health of the dogs but could also provide valuable information about the genetics,
retinal biology, molecular pathogenesis of RPs and possible environmental factors
complementing existing human studies. Furthermore, gene discoveries would
establish large animal models for retinal gene therapies [6–7]. Today, over dozen
PRA genes have been described in dogs [1], [3], [8–23], and many remain still to
be found.
We have recently characterized a unique type of retinal degeneration in the
Swedish Vallhund (SV) breed [24]. (S1 Figure). The phenotype of this disease
differs from most known forms of PRA with a multifocal rather than diffuse
degeneration of the retina. Furthermore, age of onset and rate of progression vary
considerably even in the littermates. Clinical signs progress in three stages ranging
from diffuse multifocal red/brown discoloration of the tapetal fundus without
associated visual deficits (Stage 1), to geographic retinal thinning/degeneration
with mild to moderate signs of night-blindness (Stage 2), to more diffuse retinal
thinning/degeneration affecting most of the tapetal fundus and associated with
night-vision loss and severely impaired day-vision (Stage 3) [24]. This disease
affects both the RPE and rod and cone photoreceptors with an excessive
accumulation of autofluorescent material within the RPE [24]. Since the known
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canine PRA genes did not associate with the disease [24], we embarked a study
here to identify the genetic cause.
Materials and Methods
Study cohort
Blood samples from SVs across various countries were collected to the canine
DNA bank at the University of Helsinki, Finland with owner’s consent and under
the permission of animal ethical committee of County Administrative Board of
Southern Finland (ESAVI/6054/04.10.03/2012). Altogether 436 samples were
collected, including 93 cases and 76 controls. All affected dogs were examined by
certified veterinary ophthalmologists at least once in Finland, Sweden or USA and
diagnosed with SV retinopathy. All the control dogs used in the genome-wide
association analysis were over 7 years of age at the time of eye examination by
veterinary ophthalmologists and none of them were diagnosed with any retinal
abnormalities. Genomic DNA was extracted from EDTA blood samples using
Chemagic Magnetic Separation Module I (MSM I) (Chemagen Biopolymer-
Technologie AG, Baeswieler, Germany) according to the manufacturer’s
instructions.
Retinal samples from four affected SVs and a PRA-free Australian Cattle Dog
and a Belgian Shepherd became available due to euthaniziation for unrelated
causes, and were collected post mortem with owners’ consents. RNA was extracted
using RNeasy Mini Kit (Qiagen) according to manufacturer’s instructions.
A pedigree (S2 Figure) modified from related manuscript, Cooper et al. [24]
(S1 Figure) was constructed around the affected dogs using Genopro software
and the genealogical data available in public canine registries such as the Finnish
Kennel Club’s Koiranet, the Swedish Kennel Club’s Hunddata databases or as
informed by the owners.
Genome wide association study
To map the retinopathy locus in SVs a genome-wide association mapping was
performed with 18 cases and 10 controls using Illumina Canine SNP20 BeadChip
array (San Diego, CA, USA). Genotyping was performed at the FIMM Technology
Center. The genotyping data was analyzed using PLINK 1.07 analysis software
[25]. A total of 22,362 markers were initially included for the analysis. No
individual were removed for low genotyping success of 95%. Missingness test of
95% removed 87 SNPs and the average genotyping rate per individual remained at
99.9%. A total of 8,078 SNPs had minor allele frequency of less than 5% and were
removed. None of the SNPs deviated from Hardy-Weinberg equilibrium based of
HWE test of P,50.0001. After frequency and genotyping pruning, 13,699 SNPs
remained in the analysis.
To compare the affected dogs and healthy control dogs an allelic case-control
association test was performed and significance values from this analysis were
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used to generate a whole-genome association plot using R-program [26]. Identity-
by-state (IBS) clustering and CMH meta-analysis (PLINK) were used to adjust for
population stratification. Genome-wide corrected empirical p-values were
determined applying 50,000 permutations to the data. Besided PLINK the data
was analyzed using R-implemented GenABEL software [27] (data not shown).
Replication study
A replication study for the best associated SNPs at CFA17 (BICF2G630207991)
was performed in additional 34 cases and 26 controls. We performed a standard
PCR, including 1.2 U Biotools DNA Polymerase (Biotools, Madrid, Spain),
1.5 mM MgCl2 (Biotools, Madrid, Spain), 200 mM dNTPs (Finnzymes, Espoo,
Finland), 16 Biotools PCR buffer (Biotools, Madrid, Spain), 0.83 mM forward
GCTGCTTCCTTTTTGCTCAT and reverse GGTGCTACGTTTGACAGCAA pri-
mers (Sigma Aldrich, St. Louis, USA) and 10 ng template genomic DNA. Reaction
mixtures were subjected to a thermal cycling program of 95 C˚ for 10 min, 35
cycles of 95 C˚ for 30 s, 30 s 58 C˚, 72 C˚ for 60 s and a final elongation stage of
72 C˚ for 10 min. ExoSap (USB Corporation, Ohio, USA) purified fragments were
sequenced at the FIMM Technology Center using ABI 3730xl DNA analyzer
(Applied Biosystems, Foster City, California, USA). Sequence analysis was
performed using Variant Reporter software (Applied Biosystems, Foster City,
California, USA).
Targeted capture and re-sequencing
The associated region of 6.1 Mb on CFA17 (37.53–43.64 Mb, CanFam2.0) was
resequenced in four affected SVs, four healthy SVs and 16 dogs from two other
breeds, Dandie Dinmont Terrier and Staffordshire Bull Terrier. The SV samples
were selected based on the opposite haplotypes in cases and controls (Fig. 1B).
The region was captured using custom designed probes (according to the build
2.1 of the canine genome reference sequence) and Roche Nimblegen solution
based capture method followed by paired-end sequencing using the Illumina
HiSeq2000.
The data analysis included quality control, alignment, variant calling and
annotation of the variants. Quality control was performed using FASTX toolkit
(http://hannonlab.cshl.edu/fastx_toolkit/index.html) to remove the low quality
bases called by the sequencing machine. Base call accuracy of 99% i.e. bases with
Phred scores ,Q20, were trimmed to reduce false positives during variant calling.
The quality passed paired-end reads were aligned to the build 3.1 of the canine
genome reference sequence with Burrows-Wheeler (BWA) aligner tool with
default parameters [28]. After mapping, the reads that mapped to the targeted
region were extracted followed by the removal of potential PCR duplicate reads
using Samtools 0.1.18 [29]. Local realignment around potential indel sites and
base quality scores recalibration were implemented using GATK [30] and fix
mate-pair information using Samtools [29] to improve the quality of the sequence
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Fig. 1. Results of the genome-wide association study. Genome-wide association analysis identifies the retinopathy locus in the SV breed. A) Manhattan
plot with tentative association on CFA17 (praw57.7610
25), replication analysis supported the association (prepl52.7610
25) and was confirmed by
combined analysis (p54.361028). CFA39 represent the X chromosome. B) A close-up of the associated region on CFA17, which spans from 38.16 Mb to
43.64 Mb. C) The associated region harbors over hundred genes, including a known PRA gene, MERTK.
doi:10.1371/journal.pone.0114552.g001
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data before variant calling. The sequence alignments were then directed to the
variant calling programs GATK [30] and Samtools [29] to identify the SNPs and
short indels present within the samples. Pindel program was further used to
identify indels and structural variants [31]. Finally, the identified variants were
annotated against NCBI and UCSC databases to find out the variants present in
the coding and non-coding regions. The annotation was performed using SnpEff
[32] and in-house custom R-scripts. The dbSNP131 database was utilized to
identify known polymorphic variants. To identify the case-specific variant, the
data was filtered against the controls and 16 other dogs from two breeds under a
recessive model using our in-house R-scripts. To study the CNVs and repeat
elements (SINE, LINE), a heatmap analysis was performed by comparing
normalized read depths in each position between cases and controls.
Validation of candidate causative variants
The tentative disease causing variants identified by resequencing, were genotyped
in a large sample cohort of SVs (Table 1) and from eight unaffected dogs from
two other breeds for the breed specificity. The identified variants were categorized
based on type and position: non-synonymous first, followed by variants in the
non-coding RNAs, UTR regions, and conserved intergenic and intronic regions,
respectively (Table 1). The primers for the validated markers are available upon
request. The association of each variant with the disease was calculated by PLINK
[25].
Expression analyses
Retinal RNA samples were studied to screen MERTK transcript for mutations and
to quantitate transcript levels of four retinal candidate genes, MERTK, NPHP1,
ANAPC1 and KRCC1 between the affected (n54) and unaffected (n52) dogs. The
MERTK mRNA sequence (XM_005630437.1) was amplified using Biotools
(Biotools, Madrid, Spain)) polymerase and PCR protocol described in the
replication section with annealing temperature of 60 C˚. Amplicons were Sanger
sequenced for mutations.
To quantitate transcript levels, a real time PCR was performed using Applied
Biosystems’7500 Fast Real-Time PCR machine and Universal SYBR Green Master
(Roche). RT-PCR was carried out on equal amounts of retinal RNA in each
sample by using the High Capasity RNA-to-cDNA kit (Applied Biosystems). RT-
PCR was carried out in 0.25 mM of forward and reverse primes in a total reaction
volume of 20 ml. The primers used for mRNA amplification and real time PCR are
available upon request. A housekeeping gene, GAPDH was used as a normal-
ization control, and triplicate samples were used for all reactions. The efficiency of
the reaction was calculated from a seven-point dilution series. No significant
differences were detected in the efficiencies between the housekeeping and target
reactions, and the comparative DDCt-method could be used to determine relative
expression differences. Statistical significance of the expression differences was
A Novel Canine Retinopathy Associated with MERTK
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calculated by using the Student’s t-test on normalized mean cycle threshold (Ct) -
values. PASW Statistics 18 software SPSS (IBM) was used to perform the statistical
tests.
Results
We have recently identified a novel type of retinal degeneration in SVs with a
likely recessive mode of inheritance [24] and aimed to map the disease locus here
by expanding the SV study cohort across different countries in Europe and the
US. We performed a GWAS in a cohort of 18 cases and 10 controls using
Illumina’s canine 22k SNP array. Genotyping data was analyzed by a linear
regression (PLINK) and mixed model approaches (GenAbel, data not shown). No
significant population structure was identified by genome wide IBS clustering
(l51.1). We identified a tentative locus on CFA17 (praw57.7610
25,
pgenome50.13) with the most highly associated SNP, BICF2G630207991 (Fig. 1A).
To confirm the association, we genotyped the best associated SNP on CFA17 in
additional 34 cases and 26 controls (prepl52.7610
25). The combined analysis
(GWAS and replication) supported the association (pcom54.3610
28) (Fig. 1A).
According to the combined analysis, 82% (41/50) of the cases and 30.5% (11/
36) of controls were homozygous for the risk allele at CFA17 given the
(OR511.2). Eleven unaffected dogs that were homozygous for the risk allele were
all eye examined healthy after 6 years of age, however, it is possible that the dogs
become affected later as the age of onset and disease progression varies even in the
littermates [24]. Reduced penetrance of the disease may be linked to the large
phenotypic variation or possible genetic or environmental modifiers [24].
Candidate gene analysis
The associated region has a homozygous risk haplotype in the cases (17/18),
spanning a 6.1 Mb region from 37.5 Mb to 43.60 Mb (Fig. 1B). One of the cases
clearly carries a different haplotype from the rest of the cases and could be a
phenocopies due to other reasons (Fig. 1B). The region contains 102 genes of
which anaphase promoting complex subunit 1 (ANAPC1) [33], c-mer proto-
oncogene tyrosine kinase (MERTK) [34–41] and nephronophthisis 1 (NPHP1) [42–
43] have been previously associated with retinal disease or retinal function
(Fig. 1C). These genes were selected for exonic mutation screening, revealing
three non-synonymous coding variants p.A369P (g.36405419) in MERTK,
p.H86R (g.3512824) in NPHP1 and p.V734I (g.36279583) in the ANAPC1
(Table 1).
The pathogenicity of the coding variants was predicted based on the
bioinformatics prediction softwares Polyphen2.0 [44] and SIFT [45], which
evaluate the evolutionary conservation of the residues across species. The MERTK
p.A369P and the ANAPC1 p.V734I variants were predicted to be benign while
NPHP1 variant as likely pathogenic. However, when we genotyped all three
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coding variants in 33 eye examined unaffected SVs (Table 1) and eight dogs from
two other unaffected breeds, Whippet and Finnish Lapphund, we found all of
them in unaffected SVs and in the two other breed with a moderate frequency,
suggesting them as polymorphisms rather than causative.
Targeted resequencing
To identify the causative mutation, we performed a targeted resequencing of the
entire 6.1 Mb associated locus in eight SVs and 16 other dogs from Dandie
Dinmont Terrier and Staffordshire Bull Terrier breeds. We reached an average
98.8% sequence coverage across the locus in each dog and found altogether 86,160
single nucleotide variants (SNVs) and 2,294 indels (S1 Table). After filtering the
variants under the recessive model altogether 408 SNVs and 70 indels were shared
between the SV cases (S1 Table). The canine reference sequence (CanFam3.1) was
used to annotate the identified variants. Although 102 genes have been annotated
in the capture region, targeted resequencing revealed only one additional new case
specific coding variant, p.L97R, in the lysine-rich coiled-coil 1 (KRCC1) gene
(XP_005630523.1). Further analysis of this variant in 51 additional affected and 33
unaffected SVs and in two other unaffected breeds, Whippet and Finnish
Lapphund, did not support segregation and indicated that is found in other non-
affected breeds (Table 1).
Since the identified coding variants did not segregate with the disease, we next
selected 30 non-coding variants across conserved (UCSC conservation scores)
[46] regions of the top candidate genes for further analyses in additional samples
(Table 1). However, none of these variants segregated either with the disease.
Possible presence of case-specific CNVs and repeats such as, SINEs and LINEs
were studied by a read depth-based heatmap analysis between the cases and
controls. No case-specific differences were found in the read depths across the
associated region (data not shown).
Collectively, these genomic analyses did not reveal a causative mutation but
identify the strongest association with the SNP (BICF2G630207991) in the intron
of the MERTK gene. This marker was therefore further tested in 400 SVs from our
DNA bank revealing a very high carrier frequency (59.9%) and a significant risk
for homozygosity (p56.3610227, OR518.5 with 95%CI510.3–33.2).
MERTK transcript analysis
Because our genomic analyses did not reveal the causative mutation, we decided
to sequence the MERTK mRNA for possible abnormal splicing or other events
from the retinal samples, including the neuro-retina and RPE of two affected SVs
and an unaffected dog available. Sequencing revealed the p.A369P variant found
in the genomic analyses in the affected dogs but did not reveal any additional
variants or abnormal splicing events.
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Expression analysis of the retinal candidate genes
We obtained retinal tissue samples from four retinopathy affected SVs and two
control dogs and used them to quantitate transcript levels of the four retinal
candidate genes, MERTK, NPHP1, ANAPC1 and KRCC1 in the critical region.
Real-time PCR revealed a 6.5-fold upregulation of the MERTK gene in the affected
dogs while no difference was found in the NPHP1, ANAPC1 or KRCC1 genes
(Fig. 2). This result suggests that a regulatory mutation outside the coding region
results in the overexpression of MERTK, which then leads to retinopathy in the
affected dogs.
Fig. 2. Retinal upregulation of MERTK in the affected SVs. The retinal mRNA levels of MERTK, NPHP1,
ANAPC1 and KRCC1 genes were compared between affected (n54) and unaffected dogs (n52). A specific
overexpression of MERTK was found in the affected SVs. The relative mRNA expression levels are
represented as a fold change. Error bars denote the standard error of normalized Ct-values. *p#0.0001 (two-
tailed t-test p-value).
doi:10.1371/journal.pone.0114552.g002
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Discussion
We have previously identified a unique form of PRA in the SV breed and show
here genetic and functional evidence that the disease is associated with a known
human RP gene, MERTK. The SV breed is small worldwide, which is reflected
with extensive linkage disequilibrium of the associated region. The region harbors
over 100 genes, including some that have been associated with retinal function or
retinal degeneration in human and rodent models, such as ANAPC1, MERTK and
NPHP1. Although we found several coding and regulatory variants in these retinal
candidate genes, none of them followed appropriate segregation pattern and were
present in other unaffected breeds, excluding them as candidates for the disease.
However, while the causative variant remains to be found, positional and
functional evidence support the role of MERTK in the SV retinopathy.
First, our genetic data identified the best association within the MERTK gene,
and this was 100 times stronger than in any other regions of the gene-rich locus.
This result strongly suggests that the cause of the disease lies in the identified
region within or nearby MERTK. Second, from the three retinal genes in the
critical region, MERTK appears as the most likely candidate based on its function
and clinical significance in the retinal degeneration in human and rat [35], [39],
[41], [47]. The MERTK protein is a member of the TAM receptor tyrosine kinase
and is expressed in the retinal pigment epithelium (RPE) plasma membrane [48].
It participates in apoptotic cell clearance and cytoskeleton regulation with anti-
inflammatory properties [49]. Human recessive MERTK mutations have been
associated with several phenotypes including RP, rod cone dystrophy and early
onset, childhood blindness [34], [36–38], [47], [50–57]. Progressive loss of
photoreceptor cells in MERTK-deficient Royal College of Surgeon (RCS) rats was
suggested to result from the lack of the cooperation between the photoreceptor
and the RPE cells [35].
The analysis of the MERTK transcript isolated from the affected retinas
indicated an intact transcript sequence without additional coding sequence or
splicing abnormalities. However, an unexpected 6.5-fold up-regulation of the
MERTK transcript was found in the affected retina. This was specific to MERTK,
since no changes were found in the transcript levels of the other three candidate
genes, NPHP1, ANAPC1 and KRCC1 in the same retinal tissues (Fig. 2).
Potential explanations of the increased transcription of MERTK might include
i) the presence of a regulatory mutation in the MERTK gene, ii) a massive
infiltration of MERTK positive inflammatory cells into the RPE [49], iii) normal
variation in the MERTK expression due to circadian rhythm of the RPE
phagocytosis peaking at the daily onset of light [58] or iv) the presence of a
regulatory variation outside MERTK affecting its ligands or MERTK-induced
cellular physiology [59]. The hypotheses ii and iii appear unlikely, since our
routine histopathology was not indicative of invasion of inflammatory cells in the
affected retina [24], and the retinal samples for the transcript quantification were
harvested several hours after the phagocytosis peak when MERTK should not be
active and elevated. Our genetic data points to a cause within MERTK not outside.
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The presence of a MERTK-specific regulatory mutation is more likely and our
future efforts will focus on the MERTK gene and surrounding regions, including
the promoter region, upstream enhancers and possible UTR miRNA binding sites.
Overexpression of MERTK has been associated with the variants in the 3UTR
miRNA binding sites [60].
Previous MERTK-related retinal degenerations have been associated with
recessive loss-of-function mutations [34], [36–38], [47], [50–57]. The question
how overexpression of MERTK may lead to the multifocal retinopathy in the
affected SVs remains unknown, although several possible hypotheses can be
speculated based on the diversity of the MERTK functions in various models.
First, MERTK can activate several intracellular canonical signaling pathways,
including phosphoinositide 3 kinase, PI3K/AKT, pathway including phospholi-
pase C, ERK1/2, Ras, and MAP kinase and JAK/STAT pathway [61], which could
lead to increased or abnormal apoptosis in the local regions of the RPE.
Second, overexpression of MERTK has been shown to induce efferocytosis in
cancer cell lines [59]. Similarly, overactive MERTK in the RPE could increase the
efferocytosis of the POS, lead to an accumulation of photoreceptor debris in the
RPE and subsequent degeneration of photoreceptors in the affected dogs. Human
MERTK patients show deposit of autofluorescence consisting of photoreceptor
outer segment (POS) membranes and their by-products, including accumulating
lipofuscin in the outer retina [41], [51]. Similarly in RCS rats, an abnormal
accumulation of outer segment debris between photoreceptor outer segment layer
and the RPE occurs, prior to photoreceptor cell death [62–64]. In the RCS rats,
RPE cells fail to engulf POS, which causes the accumulation of POS debris in the
subretinal space [65]. The SV retinopathy affects both the RPE and rod and cone
photoreceptors with an excessive accumulation of autofluorescent lipofuscin-like
material within the RPE [24].
Third, the MERTK receptor has a soluble form, sMer [66] with an antagonistic
role to full-length MERTK. sMer can bind to Gas6 and inhibit Gas6-mediated
MERTK activation [66], which in turn could result in the impaired phagocytosis
and retinopathy. sMer is posttranslationally generated from the MERTK receptor
by the ADAM17 cleavage [66] and its expression patterns in the affected retina
and RPE should be studied at the protein level.
Fourth, MERTK overexpression has been shown to result in an altered
localization of the MERTK protein in the nuclear compartment [67]. In the RPE,
this model could lead to a net loss-of-function effect of the MERTK activity as
seen in the recessive RP cases.
Finally, MERTK is expressed in macrophages that participate in the
phagocytosis [68]. Constitutive overexpression of MERTK in the macrophages
could result in the enhanced local efferocytosis in the RPE, which in turn, would
further promote MERTK activity and undesired apoptosis and loss of
photoreceptors.
Upon confirmation of the MERTK overexpression with subsequent down-
stream mechanisms, existing MERTK inhibitors [69] may provide a therapeutic
option for the retinopathy dogs. MERTK overexpression is characteristic to several
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cancers and inhibition in those models has been found efficient [69–70]. A clinical
trial with MERTK inhibitors remains as an exciting possibility not only to treat
canine patients but also to better understand the related disease mechanisms and
MERTK biology in the eye.
The uniqueness of the SV retinopathy is based on the retinal disease phenotype,
the variation in age of onset and in the rate of disease progression. This suggests
that genetic and/or environmental disease modifiers likely contribute to the
disease phenotype. Our GWAS data with a modest samples size revealed a single
locus with a possible reduced penetrance. The vast majority of the affected dogs
are homozygous for the risk haplotype, however, the phenotypic variability in SVs
may be related to the particular type of regulatory mutation causing the
upregulation of MERTK in combination with possible environmental factors.
Three additional coding variants were found in other genes. A predicted
pathological variant, p.H86R, was identified in the NPHP1 gene, which encodes
for nephronophthisis 1. NPHP1 is widely expressed in many tissues and localized to
the photoreceptor-connecting cilia at the junction of the inner segment and outer
segment [71]. The gene has been implicated in an autosomal recessive, juvenile
nephronophthisis 1 [72] with infrequent retinal degeneration [73]. Nphp1-
deficient mice present an early-onset rapidly progressing degeneration of the outer
and inner segments and nuclei, losing the photoreceptors within the first 8
months of life [74]. Although the p.H86R variant was predicted to be
pathological, its homozygous presence in other unaffected SVs and breeds exclude
its causative role.
The third coding variant (p.V734I) was identified in the ANAPC1 gene. This
gene has been implicated in the normal eye development in Drosophila. The
shattered (shtd) mutation in the fly leads to a failure in G1 arrest during the
mitosis, causing a defective arrangement of photoreceptor cells and other
developmental problems in the eye [75]. Again the identified variant in our SVs
was not case- or breed-specific ruling it out as the cause of the disease.
The fourth non-synonymous coding variant in the associated region, p.L97R,
was found in the KRCC1 gene, which encodes a lysine-rich coiled-coin protein 1,
with an unknown function. However, the KRCC1 variant was also present in other
unaffected dogs and did not segregate with the disease.
Similarly, a large number of potential regulatory variants were found in the
conserved regions across the associated region but validation experiments for 30
of them did not support an appropriate segregation pattern. We may have missed
the causative mutation in MERTK due to technical reasons despite high quality
resequencing data. Targeted capture is not efficient in repetitive regions, which are
often lost already at the target design. Another challenge relates to possible larger
structural variants such as CNVs, which are not easy to pinpoint in the
resequencing data. It is possible that some coding variants have been missed in
our analysis, however, the annotations around MERTK locus were identical in
both species and it is unlikely that coding variants were missed in the critical
region. We will consider resequencing of the whole genomes of SVs to avoid
capture-related obstacles.
A Novel Canine Retinopathy Associated with MERTK
PLOS ONE | DOI:10.1371/journal.pone.0114552 December 17, 2014 14 / 19
In conclusion, we have mapped the cause of retinopathy in SVs and show the
involvement of the up-regulated MERTK gene in the affected dogs. Our study
establishes a novel gain-of-function model for the MERTK physiology in the
retina. Future studies will include the search for the regulatory mutation and
study of overexpression-related disease mechanisms with a possibility for a
therapeutic option with MERTK inhibitors. Meanwhile, a genetic marker test can
be developed for breeding purposes to help the future SV population to reduce the
high-risk allele frequency in the breed.
Supporting Information
S1 Figure. A pedigree from a related manuscript, Cooper et al., indicates
clinically studied dogs [24].
doi:10.1371/journal.pone.0114552.s001 (TIF)
S2 Figure. Pedigree indicates the dogs that were used in the GWAS study
(marked yellow). Disease segregation suggests an autosomal recessive mode of
inheritance.
doi:10.1371/journal.pone.0114552.s002 (TIF)
S1 Table. Summary of the targeted resequencing data. The 6.1 Mb associated
region was captured and resequenced in four cases and four control SVs with
opposite risk haplotypes to identify the causative mutation.
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